Heart disease remains the leading cause of death among women globally, yet many are unaware of all contributing risk factors. While conditions such as high blood pressure, high cholesterol, smoking, ...

NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced a key publication in the ...

Over six weeks, the researchers administered twice-weekly injections of LXA 4 to diabetic mice with cardiovascular disease characterized by heart inflammation, scarring of the heart muscle, ...

Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and how that risk might be reduced. They found that the vaccines can spark a two ...

Myocarditis has become a flashpoint in debates about COVID vaccines; however, new research suggests this rare heart inflammation is a window into how powerful immune technologies sometimes misfire in ...

Phase II ARCHER trial showed a significant reduction in left ventricular (LV) mass (p=0.0117) and improvements in multiple key cardiac MRI (CMR) measures of structural heart recovery in patients with ...